Pharmacyclics hereby authorizes you to copy documents or pages published by Pharmacyclics on this Web site for your noncommercial reference use only, provided any copy you make retains all copyright or other proprietary notices and any disclaimer contained thereon. If you link to any other Web sites from this Web site, you should follow the copyright provisions of those sites.
This Web site provides selected information available about a range of disease topics. The information is not intended to be a substitute for the advice of a health care professional, or a recommendation for any particular treatment plan. Medical information changes rapidly, and it is important that consumers rely on the advice of a health care professional to employ good clinical judgment for the specific conditions of individual patients.
Pharmacyclics®, and the logo® are registered trademarks of Pharmacyclics. The use or misuse of these trademarks or any other materials, except as permitted herein, is expressly prohibited and may be in violation of copyright law, trademark law, publication rights and communications regulations and statutes. Please be aware that Pharmacyclics actively and aggressively enforces its intellectual property rights to the fullest extent of the law.
While Pharmacyclics intends to periodically update this Web site, it makes no representations or warranties as to its accuracy or completeness. Access to and use of the content is solely at your own risk, and neither Pharmacyclics nor any party involved in creating or delivering this site shall be liable for any damage of any kind arising out of the access, use or inability to access or use this site, or for any omissions or errors. Pharmacyclics reserves the right to alter or delete material from this site at any time.
Materials in this Web site may contain information that includes or is based upon forward-looking statements. Forward-looking statements give our expectations or forecasts of future events. You can identify these statements by the fact that they do not relate strictly to historical or current facts. They use words such as "anticipate," "continue," "estimate," "expect," "intend," "plan," "believe," "will," and other words and terms of similar meaning in connection with a discussion of future operating or financial performance. In particular, these include statements relating to future actions, prospective products or product approvals, future performance or results of current and anticipated clinical trials and products, expenses, the outcome of contingencies and financial results.
Any or all of our forward-looking statements here or in other publications may turn out to be wrong. They can be affected by inaccurate assumptions or by known or unknown risks and uncertainties. Many such factors will be important in determining our actual future results. As a result, all of the information in this Web site should be read in combination with our reports to the SEC. In particular, you should read the discussion of risks and other factors in our most recent Annual Report to Stockholders, our most recent Annual Report on Form 10-K, our quarterly Form 10-Q reports, as well as our other reports filed from time to time with the SEC. The information contained in such discussions covers certain risks, uncertainties and possibly inaccurate assumptions that could cause our actual results to differ materially from expected and historical results. This information should be considered in evaluating our prospects and future financial performance.
Certain links on this site lead to resources located on servers maintained by others over whom Pharmacyclics has no control. We provide links to these external sites for your convenience. As such, Pharmacyclics neither endorses nor makes any representation as to the accuracy or any other aspect of the information contained on such servers. Should any visitor to the Pharmacyclics Web site provide information such as questions, comments, suggestions, ideas, or the like through the feedback mechanisms located in the Web site, Pharmacyclics shall have no obligation of any kind with respect to such information and shall be free to destroy, reproduce, use, disclose, and distribute the information to others without limitation.
The information provided herein may contain references to ibrutinib or a use of ibrutinib which has not been approved by any regulatory agency. Providing this information should not be construed as recommending the use of ibrutinib for uses which may not have been approved by any regulatory agency. The safety and efficacy of the investigational use of ibrutinib has not been determined. There is no guarantee that the investigational uses listed will be filed with and/or approved for marketing by any regulatory agency. For additional information, you may visit www.clinicaltrials.gov
. For products approved by any regulatory agency please consult the product’s full prescribing information for a complete discussion of risks and benefits of the product for its approved indications.